FDA Inspection 1049005 — Rocky Mountain Center for Reproductive Medicine
The FDA completed an inspection of Rocky Mountain Center for Reproductive Medicine on February 28, 2018 in Fort Collins, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 28, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Collins, CO (United States)